Rep. Henry Waxman - 29th District of California

About Rep. Waxman
In the News
Constituent Services
The 29th District
About Congress
Contact Us
Home

In Washington, D.C.
2204 Rayburn House Office Building
Washington, D.C. 20515
(202) 225-3976 (phone)
(202) 225-4099 (fax)

In Los Angeles
8436 West Third Street, Suite 600
Los Angeles, CA 90048
(323) 651-1040 (phone)
(323) 655-0502 (fax)

Send a Message to Rep. Waxman


Issues and Legislation

Foreign Affairs - International Trade

April 9, 2008
Letter to US Trade Representative Susan Schwab Urging Focus on Access to Medicines
In a letter to U.S. Trade Representative Schwab, Rep. Waxman and twenty-six other Members of Congress asked that in reviewing the global state of intellectual property rights the USTR act upon the United States' commitment to respecting measures that improve access to live-saving medicines in developing countries.


April 3, 2008
Letter to U.S.
Trade Representative Susan Schwab regarding Israel's status in the USTR Special 301 Report

June 20, 2007
Letter to US Trade Representative Susan Schwab Urging Reexamination of Thailand Decision
Rep. Waxman and 34 colleagues urge the U.S. Trade Representative to reexamine the Administration's decision to put Thailand on a “Priority Watch List” because of steps taken by the Thai government to secure generic versions of three drugs for citizens in its public health program.  In the letter, the members call on the USTR to affirm the rights of countries to use the public health flexibilities recognized in international trade law.
Response

April 20, 2007
Letter to U.S.
Trade Representative Susan Schwab regarding Israel's status in the USTR Special 301 Report

March 12, 2007
Letter to US Trade Representative Susan Schwab concerning intellectual property protection and public health in FTAs with with Peru, Colombia and other developing countries
Response


January 10, 2007
Letter to US
Trade Representative Susan Schwab regarding Thailand compulsory license for HIV/AIDS drug efavirenz
Response


October 13, 2006
Letter to HHS Secretary Michael Levitt concerning a World Health Organization report on U.S. trade policy and international health

March 31, 2006
Letter to U.S. Ambassador
Portman regarding Israel's status in the USTR Special 301 Report

December 5, 2005
Letter to U.S. Ambassador Portman concerning the U.S. position on the Paragraph 6 Solution to the Doha Declaration on the TRIPS Agreement and Public Health

November 10, 2005

Letter to U.S. Ambassador Portman regarding U.S.-Andean Free Trade Agreement
Response


March 6, 2005
Letter to U.S. Ambassador Allgeier regarding Israel's status in the USTR Special 301 Report


September 30, 2004

Letter to President Bush regarding the Latin American Free Trade Agreement

Response from Colombia Minister of Social Protection

July 15, 2004

Letter to U.S. Ambassador Zoellick regarding pharmaceutical products in the Morocco Free Trade Agreement
Response

April 21, 2004
Letter to U.S. Ambassador Zoellick regarding Israel's status in the USTR Special 301 Report


December 10, 2003

Letter to U.S. Ambassador Zoellick regarding pharmaceutical products in the Central America Free Trade Agreement (CAFTA)